Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 90028-76-5
- Molecular formula
- Not available
- Molecular weight
- Not available
- Drug class
- Botanical extractflavonoid and terpene-lactone phytopharmaceutical
- Mechanism of action
- Standardised Ginkgo biloba leaf extracts contain flavonoid glycosides and terpene lactones, including ginkgolides and bilobalide. Proposed activities include antioxidant effects, modulation of platelet-activating factor, microcirculatory effects and neuroprotective signalling. Composition and pharmacology are extract-specific.
- Indications / reported uses
- Certain standardised Ginkgo biloba extracts are authorised or licensed in some countries for symptomatic treatment of mild cognitive impairment or age-related cognitive symptoms, and/or support of peripheral circulation. Uses cannot be generalised to all Ginkgo preparations or dietary supplements.
Sources: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=ginkgo.biloba2&lang=eng · https://pmc.ncbi.nlm.nih.gov/articles/PMC6488894/ · https://www.ncbi.nlm.nih.gov/books/NBK541024/